Institute of Chemistry and Bioanalytics, University of Applied Sciences-FHNW, Muttenz, Switzerland.
J Pharm Sci. 2011 Jun;100(6):2300-10. doi: 10.1002/jps.22466. Epub 2011 Jan 19.
Ceftriaxone is a third-generation cephalosporin antibiotic, which has a broad spectrum of bactericidal activity. Ceftriaxone is highly soluble as a sodium salt, but far less soluble as a calcium salt. Incompatibility of ceftriaxone with calcium and the possible formation of precipitates have been stated in the product label from early on. It was the objective of the present in vitro study to further assess the risk of precipitation of calcium-ceftriaxone in human plasma. Analytical methods were developed (high-performance liquid chromatography and flame atomic absorption spectroscopy) to quantitate calcium and ceftriaxone in human plasma supernatants and human plasma precipitates. Using high concentrations of ceftriaxone (10 mmol/L) and calcium (4.2 mmol/L) did not result in any precipitation after 2 h incubation in human plasma at 37 °C. Under conditions of forced precipitation only, formation of precipitation was observed. The identity of the precipitated material was confirmed by energy-dispersive X-ray analysis and Fourier transform infrared spectroscopy. We conclude that calcium-ceftriaxone in human plasma has an apparent kinetic solubility product constant of greater than 0.42 × 10(-4) (mol/L)(2), which exceeds the normal thermodynamic solubility product in water by a factor of 26. Under these conditions, the formation of plasma precipitates is unlikely.
头孢曲松是一种第三代头孢菌素抗生素,具有广谱杀菌活性。头孢曲松以钠盐形式高度溶解,但以钙盐形式的溶解度低得多。从早期开始,产品标签就指出了头孢曲松与钙的不相容性以及可能形成沉淀物。本体外研究的目的是进一步评估人血浆中钙-头孢曲松沉淀的风险。开发了分析方法(高效液相色谱法和火焰原子吸收光谱法)来定量测定人血浆上清液和人血浆沉淀物中的钙和头孢曲松。在 37°C 下孵育 2 小时后,即使使用高浓度的头孢曲松(10mmol/L)和钙(4.2mmol/L),人血浆中也不会发生任何沉淀。仅在强制沉淀的条件下才观察到沉淀的形成。沉淀物质的身份通过能量色散 X 射线分析和傅里叶变换红外光谱法得到确认。我们得出结论,人血浆中的钙-头孢曲松具有大于 0.42×10(-4)(mol/L)(2)的表观动力学溶解度积常数,这超过了水的正常热力学溶解度积常数的 26 倍。在这些条件下,不太可能形成血浆沉淀。